Welcome to the McGuigan Lab at Cardiff University

cu logolab logo

News:
December 2011 - Nucana, a Scottish company have announced new funding and a phase 1 trial on NUC 1031 against panctreatic cancer

December 2011 - New data released by Inhibitex reveal that INX-189 at higher doses in combination with ribavirin continued to show synergistic activity against hepatitis C

November 2011 - Inhibitex have just reported that INX-189, first synthesised in this School, produced a more than 10,000 reduction in viral load in patients treated with 200mg daily for 7 days, with very few side effects

 

Email: Chris McGuigan

Office: (029)20874537
Lab: (029) 20874551
Fax: (029) 20874537

 


The Story behind the discovery of FV100
CMcG Pic

Step forward for shingles drug - FV100
FV100

 

Click on the links below to see some details of our projects.
 

 

Our Science
VZV


HIV


Cancerso324HCMV Riboswitches Aptamers and Allosteric Ribozymes

ProTides

 

HCV


Sugar Phosphates